Relmada Therapeutics, Inc. RLMD Unrealized Losses
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlmd:UnrealizedLosses.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s unrealized losses.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s unrealized losses?
- Relmada Therapeutics, Inc. (RLMD) reported unrealized losses of $540.1K in Q1 2026.